Multipotent Mesenchymal Stromal Cells Synergize With Costimulation Blockade in the Inhibition of Immune Responses and the Induction of Foxp3 + Regulatory T Cells
Author(s) -
Takahashi Tohru,
Tibell Annika,
Ljung Karin,
Saito Yu,
Gronlund Anna,
Osterholm Cecilia,
Holgersson Jan,
Lundgren Torbjörn,
Ericzon Bo-Göran,
Corbascio Matthias,
Kumagai-Braesch Makiko
Publication year - 2014
Publication title -
stem cells translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.781
H-Index - 71
eISSN - 2157-6580
pISSN - 2157-6564
DOI - 10.5966/sctm.2014-0012
Subject(s) - foxp3 , mesenchymal stem cell , immunology , immune system , blockade , cell therapy , regulatory t cell , t cell , immune tolerance , stromal cell , splenocyte , medicine , cancer research , biology , microbiology and biotechnology , il 2 receptor , stem cell , receptor
Multipotent mesenchymal stromal cells (MSCs) from C57BL/6 (H2 b ) mice were infused with fully major histocompatibility complex‐mismatched Balb/c (H2 d ) allogeneic islets into the portal vein of diabetic C57BL/6 (H2 b ) mice, which were treated with costimulation blockade for 10 days. Their livers contained large numbers of islets surrounded by Foxp3 + regulatory T cells. MSC infusion and costimulation blockade have complementary immune‐modulating effects that can be used for a broad number of applications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom